Physician profile
Matthew D Cobb
NPI 1639229594
$3,793.42
in general payments reported to CMS, 2019-2025
10 companies · $1,305 in 2025
The $1,305 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,112 · 2020: $77.20 · 2021: $113 · 2022: $34.05 · 2024: $151 · 2025: $1,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $997 · Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $996.85 |
| Food and Beverage | $459.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,171.63 | 2019-2025 | Ortholoc 3di, Augment Injectable, 7 X 23mm Citrelock Implant |
| Paragon 28, INC. | $1,286.56 | 2025 | Apex 3d, Portfolio |
| Djo, LLC | $127.13 | 2019 | |
| Organogenesis INC. | $119.85 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $28.59 | 2020 | |
| Medtronic, INC. | $16.68 | 2022 | |
| Depuy Synthes Sales INC. | $14.81 | 2020 | |
| Wright Medical Technology, INC. | $13.87 | 2019 | |
| Arthrosurface Incorporated | $10.92 | 2019 | |
| Orthofix Medical, INC. | $3.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.